Patient Guide: ResQ201A: Clinical Trial Of N-803 Plus TISLELIZUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 9 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06745908
Status: 🟢 Enrolling Now
Condition: NSCLC Stage IV
Phase: PHASE3

Where You Can Participate

This study is available at 9 locations across the country.

Top locations include:
  • • Springdale, Arkansas
  • • El Segundo, California
  • • Glendale, California
  • • And 6 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

ResQ201A: Clinical Trial Of N-803 Plus TISLELIZUMAB And DOCETAXEL Versus DOCETAXEL Monotherapy In Participants With Advanced Or Metastatic Non-Small Cell Lung Cancer - Join Clinical Trial NCTNCT06745908

How to Join This Clinical Trial - NCTNCT06745908

Learn how to participate in this PHASE3 trial studying an investigational therapy for NSCLC Stage IV. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with NSCLC Stage IV. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
NSCLC Stage IV
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06745908 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 9 locations. Find a study site near you:

Clinical Research Site

Springdale, Arkansas 72762 - United States

Status: RECRUITING

Clinical Research Site

El Segundo, California 90245 - United States

Status: RECRUITING

Clinical Research Site

Glendale, California 91203 - United States

Status: RECRUITING

Clinical Research Site

Los Alamitos, California 90720 - United States

Status: RECRUITING

Clinical Research Site

Fort Lauderdale, Florida 33316 - United States

Status: RECRUITING

Clinical Research Site

Tampa, Florida 33612-9497 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: RECRUITING

Clinical Research Site

Cincinnati, Ohio 45267 - United States

Status: RECRUITING

Clinical Research Site

Nashville, Tennessee 37232 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for NSCLC Stage IV:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships